Transcatheter Mitral Valve Replacement: An Update on Current Techniques, Technologies, and Future Directions.
mitral
transcatheter
valve
Journal
JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004
Informations de publication
Date de publication:
08 03 2021
08 03 2021
Historique:
received:
10
08
2020
revised:
04
12
2020
accepted:
08
12
2020
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
19
8
2021
Statut:
ppublish
Résumé
Growing clinical data support the use of transcatheter therapies for significant mitral valve disease. Currently, edge-to-edge repair is the transcatheter treatment of choice, but many anatomies are not suitable. Transcatheter mitral valve replacement offers several potential advantages over transcatheter repair, most notably a greater and more sustained reduction in mitral regurgitation post-implantation, but also potential disadvantages. To enable the successful treatment of mitral valve disease in a wide range of patients and anatomies, we require an armory of transcatheter devices, including transcatheter mitral valve replacement systems.
Identifiants
pubmed: 33663778
pii: S1936-8798(20)32557-7
doi: 10.1016/j.jcin.2020.12.038
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
489-500Informations de copyright
Crown Copyright © 2021. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Funding Support and Author Disclosures Dr. Sathananthan is a consultant to Edward Lifesciences and Medtronic. Dr. Ye is a consultant to Edwards Lifesciences. Dr. Cheung is a consultant to Abbott Vascular, Medtronic, and Neovasc. Dr. Webb is a consultant to Edwards Lifesciences, Abbott Vascular, and Boston Scientific. Dr. Blanke is a consultant to Edwards Lifesciences, Tendyne, Neovasc, Circle Cardiovascular Imaging, and Gore. Dr. Leipsic is a consultant to Edwards Lifesciences, Neovasc, Abbott, Medtronic, and GE Healthcare; and has been a consultant to and holds stock in Circle Cardiovascular Imaging and HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.